– Is their clean room monitored and validated?
- Has Ribo-typing been performed?
- Has the equipment been validated to perform within its specifications?
- Can the clean room conditions be matched to time of drug compounding?
– Manufacturing procedures:
- Are there standard operating procedures in place?
- Can they be produced for verification?
- Can they electronically validate all weights of powders in each formula?
- Can photographic evidence be produced for all liquid measurements in each formula?
2. Third-party validation
– Do they serve national accounts (AmSurg, etc.) or are they vendors for GPOs?
– What other companies or agencies have inspected them (pharma, independent cGMP audits, etc.)?
– Can they provide references from other customers?
3. Leadership/customer service
– What are the resumes of top management? Are pharmacists leading the company?
– Who is available for technical questions and how fast are they answered?
– What are the qualifications of the staff and technicians at the facility?
Learn more about JCB Laboratories.
Editor’s Note: This article originally appeared in Pharm-ASC, a weekly e-mail publication by Sheldon S. Sones, RPh, FASCP, a Newington, Conn.-based consultant, pharmacist and safe medication officer.
More Articles Featuring JCB Labs:
JCB Labs Launches Blog on Clinical and Compounding Information
Understanding & Meeting the 60-Minute Rule for Compounded Medications
6 Things to Know About Pharmaceuticals and Outsourcing Pharmaceutical Solutions
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
